MarginsXMarginsX
Home › Markets › BEIGF

BeOne Medicines Ltd. (BEIGF)

BEIGF is quoted over the counter, not listed on an exchange. BeOne Medicines Ltd. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · June 9, 2026
$21.95
No trades since Jun 9, 2026; later closes repeat the last quote
1-year return
-13.2%
Market cap
The company also trades on Nasdaq as ONC; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerBEIGF, quoted over the counter
SEC CIK0001651308
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressBasel

Warning signs

Cash runway
Cash-flow positive
$5.8B cash at September 30, 2026
Share count, 1 year
+3.2%
2025-11-01 to 2026-10-30 · +9.2% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$372.4M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$5.8B cash; operating cash flow $397.6M a quarter.Report 2026-09-30
Shares outstanding114,226,079 (2026-10-30); 110,657,943 a year earlier; 104,576,740 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-05-06
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $372.4M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$1.9B$384.7M$508.7M$5.8B$866.2M$6.6B10-Q 2026-11-05
Q2 2026
2026-06-30
$1.7B$237.0M$462.8M$5.1B$859.9M$6.1B10-Q 2026-08-05
Q1 2026
2026-03-31
$1.5B$227.4M$201.3M$4.8B$852.2M$5.7B10-Q 2026-05-06
Q4 2025
2025-12-31
$1.5B$66.5M$417.3M$4.5B$845.4M$5.3B10-K 2026-02-26
Q3 2025
2025-09-30
$1.4B$124.8M$402.6M$4.0B$1.6B$5.0B10-Q 2026-11-05
Q2 2025
2025-06-30
$1.3B$94.3M$263.6M$2.8B$954.5M$4.6B10-Q 2026-08-05
Q1 2025
2025-03-31
$1.1B$1.3M$44.1M$2.5B$923.6M$4.2B10-Q 2026-05-06
Q4 2024
2024-12-31
$1.1B-$151.9M$75.2M$2.6B$1.9B$3.8B10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-05-06
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier